Back to Search Start Over

HDL-Based Therapy: Vascular Protection at All Stages.

Authors :
Poznyak AV
Sukhorukov VN
Eremin II
Nadelyaeva II
Gutyrchik NA
Orekhov AN
Source :
Biomedicines [Biomedicines] 2023 Feb 27; Vol. 11 (3). Date of Electronic Publication: 2023 Feb 27.
Publication Year :
2023

Abstract

It is known that lipid metabolism disorders are involved in a wide range of pathologies. These pathologies include cardiovascular, metabolic, neurodegenerative diseases, and even cancer. All these diseases lead to serious health consequences, which makes it impossible to ignore them. Unfortunately, these diseases most often have a complex pathogenesis, which makes it difficult to study them and, in particular, diagnose and treat them. HDL is an important part of lipid metabolism, performing many functions under normal conditions. One of such functions is the maintaining of the reverse cholesterol transport. These functions are also implicated in pathology development. Thus, HDL contributes to vascular protection, which has been demonstrated in various conditions: Alzheimer's disease, atherosclerosis, etc. Many studies have shown that serum levels of HDL cholesterol correlate negatively with CV risk. With these data, HDL-C is a promising therapeutic target. In this manuscript, we reviewed HDL-based therapeutic strategies that are currently being used or may be developed soon.

Details

Language :
English
ISSN :
2227-9059
Volume :
11
Issue :
3
Database :
MEDLINE
Journal :
Biomedicines
Publication Type :
Academic Journal
Accession number :
36979690
Full Text :
https://doi.org/10.3390/biomedicines11030711